98.50
+0.5(+0.51%)
Currency In GBp
Address
215 Euston Road
London, NW12BE
United Kingdom of Great Britain and Northern Ireland
Phone
N/A
Website
Sector
Financial Services
Industry
Asset Management
Employees
1050
First IPO Date
October 26, 2012
| Name | Title | Pay | Year Born |
| Dr. Christopher J. Hollowood Ph.D. | Chief Executive Officer | 0 | 1974 |
| Ms. Kate Butler | Chief Financial officer | 0 | N/A |
| Mr. John McDonald | Co-Founder | 0 | 1965 |
| Mr. Ben Woolven | Business Strategy and Operations Partner | 0 | N/A |
| Mr. Edward Eliot Hodgkin DPhil | Managing Partner | 0 | 1963 |
| Mr. Thomas Henderson | Co-Founder & Non-Executive Director | 0 | 1966 |
| Mr. Kenneth H. Galbraith C.A. | Chair of SIML & Executive Partner | 0 | 1963 |
| Ms. Harriet Gower Isaac | Chief People Officer | 0 | N/A |
| Ms. Fenella Dernie | Executive Officer | 0 | N/A |
| Mr. Marc Leigh Russell Perkins | General Counsel | 0 | N/A |
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.